INTRODUCTION
Progressive systemic sclerosis (PSS,l scleroderma) is a generalized connective tissue disorder characterized by inflammatory, fibrotic, and degenerative tissue changes. Prominent vascular lesions are commonly found in the skin, synovium, and internal organs (1) . The etiology of PSS is unknown. However, the high incidence of autoantibodies (2) (3) (4) , the frequent association with Sjbgren's syndrome (5, 6) , and Hashimoto's thyroiditis, and the clinical overlap with systemic lupus erythematosus (5, 7, 8) suggest that immunologic abnormalities may be involved in its pathogenesis.
The role of antitissue antibodies in patients with PSS remains unknown (2, 9) . The only immunoglobulin deposition found to date in the tissue of patients with PSS occurs in the glomeruli and the intralobular arteries of the scleroderma kidney (10) . Lymphocyte accumulation within tissue of patients with PSS is common (11) (12) (13) .
In delayed hypersensitivity skin tests and with in vitro response of lymphocytes to phytohemagglutinin as an indicator of cell-mediated immunity, patients with PSS responded normally (14) . Circulating lymphocytes in patients with PSS have been found to be cytotoxic to cultures of fibroblasts, epithelial, and muscle cells (15) . In addition the lymphocytes of patients with PSS release leukocyte migration inhibition factor (MIF) when cultured with autologous lymphocytes or with human liver microsomes or mitochondria (16) .
The potential role of circulating lymphocytes as factors in the pathogenesis of PSS was studied. Lymphocyte transformation, the release of macrophage inhibition factor in response to skin extracts from patients with PSS and normal skin, and direct lymphocyte cytotoxicity to skin fibroblasts were evaluated.
METHODS
Patients. 30 patients who met criteria for the diagnosis of PSS (scleroderma) were studied (1) . There were 23 women and 7 men who ranged from 18 to 69 yr in age. The patients had been diagnosed from 7 to 264 mo before testing. These individuals all had abnormal thickening and tightness of the skin (scleroderma) and exhibited Raynaud's phenomenon. Esophageal dysfunction and pulmonary fibrosis and/or diminished pulmonary diffusing capacity were also present. In 18 there was diffuse scleroderma with involvement of the skin of the proximal portions of the extremities and the trunk, as well as of the fingers, hands, and face (classical scleroderma). 12 of the patients met the criteria of CREST syndrome, as previously defined (17, 18) . In this form of PSS, there is prominence of calcinosis, Raynaud's phenomenon, esophageal dysfunction, limited involvement of the skin (often confined to the fingers) (sclerodactyly) and face, and telangiectasia. The individuals with the CREST syndrome have a relatively benign and protracted course of illness before the appearance ofdistinctive internal manifestations.
Controls consisted of nine patients with rheumatoid arthritis, three with systemic lupus erythematosis (each fulfilling diagnostic criteria of the American Rheumatism Association), one patient with mixed connective tissue disease (19, 20) and 16 Migration inhibition test. 25-30 ml of sterile mineral oil was injected into the peritoneal cavity of normal guinea pigs. 72 h later, the animals were sacrificed and 100 ml of sterile Hanks' balanced salt solution injected into the peritoneal cavity. The fluid was collected and centrifuged at 264 g for 8 min. After three washes in cold balanced salt solution, the cell pellets were suspended in 10 vol of cold medium 199. The macrophages were counted and lymphocytes added so that 15% of the total cell suspension consisted of lymphocytes obtained from the patient. Capillary tubes were filled with the cell suspension, centrifuged, and cut at the cell-fluid interface. The capillary tube containing the cells was placed in Lab-Tek chamber slides (no. 4804, Lab-Tek Products, Div. Miles Laboratories, Inc., Naperville, Ill.) which were divided into eight separate chambers. To each of the chambers 0.4 ml of medium 199 containing 15% heat-inactivated fetal calf serum was added. A 1:10 final dilution ofthe various skin antigens was included in the medium of some chambers while the control chambers did not receive antigen. An additional control included with each experiment was macrophages without added lymphocytes.
The chambers were incubated for 18-24 h at 37°C. The area of migration was determined by projecting and tracing the image of the cellular migration within each chamber on a sheet of paper. The images were cut out and weighed. The migration index was calculated by dividing the average area of migration with antigen by the average area of migration without antigen and multiplying by 100.
All patients were tested in triplicate and the results used only if the SD was less than 15% of the mean. Migration inhibition was considered to be positive when it was less than 2 SD ofthe average migration inhibition ofthe 16 - The cells were incubated at 37°C for 24-72 h. The supernatants were then removed from each well and the wells washed once with 1 ml of medium 199. To each well was added 1 ml of 2% Triton X-100 (Rohm & Haas Co., Philadelphia, Pa.) and after 24 h the Triton was removed and the wells were washed once with 1 ml of water. The percent cytotoxicity was calculated by dividing the amount of (25) . (Table I) . Only the patients with the CREST syndrome had stimulation indices slightly (P < 0.025) different from the normal controls when tested against the normal skin extract in PBS. The percentages of patients having stimulation indices greater than two to each of the antigens are shown in Table II . These results were not significant, at a P value of less than 0.05. The lymphocytes were tested at final antigen dilutions ranging from 1:100 to 1:10,000. Every patient tested had a stimulation index to phytohemagglutinin over 40. No significant differences were found in the mean counts per minute for background (1,267±560; 1,573+573; 1,085+740 cpm), phytohemagglutinin stimulation (71,394±+37,698; 93,559+61,572; 61,870+40,303), or skin antigen stimulation (2,091+625; 2,690±+1,261; 1,819+819) when the normal controls were compared with the diffuse scleroderma and CREST syndrome patients. Similarly, the mean counts per minute of those patients with positive MIF responses did not differ from the patients whose lymphocytes did not produce MIF.
The direct cytotoxicity results are given in Table III . No significant differences were found between the cells of patients with diffuse scleroderma and normal controls. This was true whether the fibroblasts were in early passages or skin cultures after repeated passages. Skin biopsies were obtained from 17 patients with diffuse scleroderma. In 11 of the biopsies no lymphocytes bound fluorescein-labeled anti-immunoglobulin sera, yet eight of these had lymphocytes present on a section stained with hematoxylin and eosin ( Table IV) . Of the eight, seven were found to have only T lymphocytes in the tisstue (Fig. 3) . DISCUSSION The production of MIF to an antigen indicates that lymphocytes are sensitized to that antigen (26) (27) (28) Of these, all but four had no change in reactivity. Three patients who were positive subsequently showed negative reactions in the MIF assay and one patient initially negative became positive. Several of the normal controls were studied at multiple time intervals and none of these ever became positive. In those patients who showed a change of reactivity, no change in the activity of their disease was noted. However, long-term followup may be needed to ascertain the significance of the change in lymphocyte reactivity with the clinical course of disease.
HLA typing in this group of patients has previouslv been reported (29) . There was no association between a particular HLA-A or B locus and the ability to respond with the production of MIF. In addition, preliminary results did not support an association between a particular HLA-D antigen and the ability to produce MIF (30) .
Patients with PSS have a perivascular lymphocytic infiltrate in the dermis (12) . It has recentlv been shown that substances derived from activated lyvmphocytes can stimulate fibroblasts to synthesize collagen (31) . Thus, the sensitized lymphocvtes may be a factor in the pathogenesis of PSS. Indeed, our finding of predominantly T lymphocytes in biopsies of skin from the patients sttudied (Table IV) is compatible with this interpretation. Due to the variability in the amount of lymphocyte infiltrate found on multiple biopsies of individual patients, no correlation with MIF production was possible.
In lymphocyte transformation, the mean stimulation index of the PSS patients was slightly higher than that of the controls. However, the only statistically significant result was obtained when the patients with the CREST syndrome were stimulated with a normal skin extract in PBS. All of the patients demonstrated normal reactivity to phytohemagglutinin both in the presence and absence of the skin extract. The dissociation between lymphocyte transformation and MIF results mav indicate a selective alteration in a lymphocyte subpoptulation (32) , or the greater sensitivity of the migration inhibition test than the lvmiphocyte transformnation assay. A similar dissociation of responsiveness has been demonstrated after the immunization of guiinea pigs to collagen (33) . The mean stimulation index of the patients who had a positive MIF response was not significantly different from those patients who were nonresponsive in the MIF assay.
Our studies did not reveal lymphocyte cytotoxicity to normal or PSS fibroblasts. Currie, et al. (15) demonstrated that patients with PSS had lymphocytes cytotoxic for fetal fibroblasts and epithelial and muscle cells. The difference between these findings and ours may be related to our use of adult tissue and not a cell like the L-cell line of fibroblasts, which are more sensitive to cell-mediated cytotoxicity (34) .
Patients with diffLse scleroderma responded similarly to both normal and PSS skin extracts. Fleischmajer and Krol (35) have reported that a saline extract of scleroderma skin has the same concentration of hexose and hexosamine as well as of normal soluble protein. Some patients appeared to be reactive to glycoproteins FIGURE 3 B. Same section of skin biopsy as in 3A, reacted with rabbit antiserum specific for T lymphocytes and fluorescein-labeled goat anti-rabbit IgG. All of the lymphocytes in the focal accumulation reacted with the antiserum (160x). C. Same biopsy as 3A, but reacted with fluorescein-labeled anti-human immunoglobulin serum. No lymphocytes were labeled (160x). extracted in KCl. However, no difference was noted between PSS skin and normal skin.
These studies, concerning cell-mediated immunity to skin antigens in patients with PSS, indicate that lymphocytes in patients with diffuse scleroderma, unlike other connective tissue diseases with the exception of mixed connective tissue disease, are sensitive to skin extracts and may release MIF. The significance of this finding in the pathogenesis of PSS can only be speculative. However, the observation that lymphocyte mediators can stimulate collagen synthesis (31) is intriguiing and stuggests that a cell-mediated immune response to skin antigens may be a factor in the pathogenesis of diffuse scleroderma.
